Salute e Benessere
Melatonin Market to Reach USD 3.0 Billion by 2030 as Sleep Health, Supplements, and Clinical Applications Drive Global Demand
Global players like are actively expanding portfolios, while biotech firms in Asia , particularly China , are scaling production of Increasing clinical validation of melatonin's role in is also expanding its medical applications.
Large-scale industrial production ensures cost efficiency and wide availability for dietary supplements and over-the-counter products.
is gaining traction among consumers seeking organic, plant- or fermentation-derived formulations. Premium pricing and rising demand in Japan and the U.S. wellness markets are accelerating adoption.
making them the largest revenue driver. Melatonin supplements are widely consumed for insomnia, jet lag, and sleep management, particularly in North America and Asia .
with growing use of melatonin in adjunct cancer care, fertility treatments, and neurodegenerative disorder management. Clinical trials are increasingly validating its therapeutic potential beyond sleep regulation.
stem from melatonin's role in photoprotection materials and specialized coatings, though this segment remains niche compared to supplements.
The U.S. dominates the melatonin market with an estimated value of Growth is driven by:
Japan's melatonin market, valued at is expanding due to:
Aspen leads in pharmaceutical-grade melatonin formulations, targeting prescription and hospital-based applications across neurology and oncology.
Both brands dominate the dietary supplement space in North America , capturing significant retail and online market share. due to increased demand for sleep support products.
Pfizer is advancing melatonin's medical adoption, with ongoing trials in neurology and oncology. Its investment in positions it strongly in the clinical therapeutics space.
BASF is a key supplier in the In 2025, it announced capacity expansions to address rising global demand.
China -based producers are critical to the synthetic melatonin supply chain, ensuring cost competitiveness for global dietary supplement brands.
The is evolving from a niche supplement category into a Four trends will shape its trajectory through 2030:
Global shift toward better sleep, preventive wellness, and innovative therapeutic applications. With the U.S. leading supplement adoption and Japan pioneering natural melatonin integration into functional foods, the market presents
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.
Sai Kiran
DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad , Telangana 500039
+1 877-441-4866
Sai.k@datamintelligence.com
Logo: https://mma.prnewswire.com/media/1858619/3573087/DataM_Intelligence_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/melatonin-market-to-reach-usd-3-0-billion-by-2030-as-sleep-health-supplements-and-clinical-applications-drive-global-demand-302577118.html